Virtual Medicinal Product (VMP)
-
Leuprorelin 11.25mg implant pre-filled syringes
Name Details
Current Name
Leuprorelin 11.25mg implant pre-filled syringes
|
Start Date
01-05-2024
|
End Date
|
Previous Name
Leuprorelin 10.72mg implant pre-filled syringes
|
Start Date
01-01-2020
|
End Date
30-04-2024
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- pre-filled disposable injection
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Prolonged-release subcutaneous implant
- Ontology Form/Route
- implant.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L02AE02
SNOMED Codes
Code
|
Start Date
|
End Date
|
38007811000001100 |
01-01-2020 |
|
VMP Ingredients
Name
Leuprorelin acetate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
11.25
Strength and UOM (Dmr)
Parent Products
-
VTM
Leuprorelin
-
VMP
(Current) Leuprorelin 11.25mg implant pre-fill...
Virtual Medicinal Product Pack (VMPP) Information